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This paper presents simple, rapid, precise and accurate stability-indicating HPLC and CE methods,
which were developed and validated for the determination of nitrendipine, nimodipine and nisoldipine.
These drugs are calcium channel antagonists of the 1,4-dihydropyridine type which are used in the
treatment of cardiovascular diseases. Experimental results showed a good linear correlation between
the area and the concentration of drugs covering a relatively large domain of concentration in all cases.
The linearity of the analytical procedures was in the range of 2.0–120.0 mg mL1 for nitrendipine, 1.0–
100.0 mg mL1 for nimodipine and 100.0–600.0 mg mL1 for nisoldipine, the regression determination
coefficient being higher than 0.99 in all cases. The proposed methods were found to have good precision
and accuracy. The chemical stability of these drugs was determined under various conditions and the
methods have shown adequate separation for their enantiomers and degradation products. In addition,
degradation products produced as a result of stress studies did not interfere with the detection of the
drugs’ enantiomers and the assays can thus be considered stability-indicating.
Introduction
In order to guarantee the stability of a drug there is a need to
understand the nature and extent of decomposition, the mecha-
nism, and the kinetics of the degradation reaction. The major
result of decomposition is a loss of potency and/or change in the
physicochemical properties.1
In addition, products formed during storage and dispensing
may affect the efficacy and safety of drugs.2–4 The chemical,
pharmacological and toxicological properties of drugs may be
changed by these products. These failures in efficiency can be
caused by changes in the integrity of the chemical structure and
stereochemistry or in the pharmacophore group.5,6
Stability-indicating methods for drugs are established and
studied in order to provide evidence on the quality of drugs when
exposed to different conditions such as pH, temperature, solvent
system composition, solution ionic strength, and light.7 From the
data obtained in these studies it is easier to determine ideal
storage conditions and re-test periods, as well as establishing
shelf lives.8 Moreover, stress testing allows the determination of
the inherent stability of a molecule when subjected to adverse
conditions by establishing the degradation pathways which is
analogous to the established metabolic profile.9
By the fact that two enantiomers of a racemic drugoften present
different pharmacological and toxicological properties, the
analytical methods should provide the enantioseparation of
racemates to determine the enantiomeric purity of a chiral drug.
There are several examples described in the literature on the
degradation of drugs and metabolites, racemization, and config-
urational changes of the enantiomers, under different conditions
such as pH, ionic strength, light, solvent and temperature.10,11
Considering the relevance of chiral drug stability to thera-
peutic efficacy, neutral dihydropyridines, nitrendipine (NTD),
nisoldipine (NSD) and nimodipine (NMD), have been studied in
this work (Fig. 1). These drugs are calcium channel antagonists
of the 1,4-dihydropyridine type used in the long-term treatment
of cardiovascular diseases, angina pectoris and hypertension.12,13
These selected drugs have a chiral carbon atom in position 4 of
the dihydropyridine ring, due to the presence of asymmetric ester
moieties.13 Since these drugs are used as racemates, the devel-
opment of stereoselective methods is required.
The fact that no study on the stability of pure enantiomers of
NMD,NTDandNSDhas been reporteduntil now, the aimof this
work was to optimize simple and feasible methods for enantio-
selective analysis of NMD and NTD by HPLC using a chiral
stationary phase, andNSD by CE, employing cyclodextrins (CD)
as chiral selector to study the stability of their enantiomers under
thermolytic, photolytic andacid/base hydrolytic stress conditions.
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Experimental
Chemicals and reagents
The active pharmaceutical ingredients (API) rac-NTD and rac-
NMD were kindly supplied by DEG (S~ao Paulo, Brazil), and the
rac-NSD was obtained from Bayer AG (Wupertall, Germany).
HPLC grade acetonitrile, isopropanol and methanol were
purchased from J.T. Baker (New Jersey, USA). Sodium chloride
was obtained from Merck (Rio de Janeiro, Brazil). The other
chemicals (analytical grade) were monosodium phosphate 1-
hydrate anddisodiumphosphate 2-hydrate purchased fromSynth
(S~ao Paulo, Brazil) and sodium chloride (NaCl) fromMerck (Rio
de Janeiro, Brazil). Water was purified with a Milli-Q PLUS
system from Millipore Corporation (Massachusetts, USA).
Preparation of standard solutions
Standard stock solutions of NTD, NMD and NSD were
prepared in methanol at a concentration of 1 mg mL1. NTD,
NMD and NSD working solutions were prepared in the
concentration range of 2.5–100 mg mL1, 1–100 mg mL1 and 50–
600 mg mL1 for each enantiomer respectively. All solutions were
obtained by dilutions of the standard solution in the same
solvent, i.e. methanol and all these solutions were stored
at 20 C in the absence of light.
Apparatus and analytical conditions
High performance liquid chromatography. HPLC experiments
were performed using liquid chromatography equipment from
Shimadzu (Kyoto, Japan), equipped with an LC 10 AT model
solvent pump, a Rheodyne model 7125 injector with a 20 mL
loop, an SPD-10 A model variable-wavelength UV detector
operating at 227 nm, and a CR6-A model integrator Shimadzu
(Kyoto, Japan). The chiral resolution of the NTD and NMD
enantiomers was carried out using the Chiral AGP column 150
4 mm internal diameter (id), 5 mm particle size (ChromTech,
H€agersten, Sweden). All chromatographic procedures were
conducted at 26  2 C.
Capillary electrophoresis. CE analyses for enantioseparation of
NSD were performed on an Agilent Technologies CE system
(Waldbronn,Germany)modelG1600A consisting of an analyzer,
an automatic sampler and a diode array detector operating at
208 nm. Agilent ChemStation Software was used for data acqui-
sition. An uncoated fused-silica capillary obtained from Micro-
Solv Technology Corporation (New Jersey, USA) of 50 mm id,
64.5 cm in total length, and 56.0 cm in effective length was used.
Before the first use, the capillary was conditioned by rinsing
with 1.0 mol L1 NaOH for 30 min, followed by water for 30 min
at 25 C. At the beginning of each working day the capillary was
rinsed with 1.0 mol L1 NaOH for 10 min, water for 10 min fol-
lowed by background electrolyte (BGE) for 15 min. The capillary
was rinsed with 0.1 mol L1 NaOH for 2.0 min, water for 2.0 min
and BGE for 5.0 min between consecutive analyses. After daily
use, the capillary was washed with 0.1 mol L1 NaOH for 15 min
followed by water for 15 min. When not in use, the capillary was
stored in water. All experiments were carried out at 20 C.
Elution order
(R)-NTD and (R)-NMD are known to be dextrorotatory while
(R)-NSD is known to be levorotatory.14 The elution order for the
NTD enantiomers was established by analyzing the pure enan-
tiomers obtained by semipreparative analysis of the 25 mL
standard methanolic solution racemates on a Chiralcel OJ
column 250  4.6 mm id, 10 mm particle size (Daicel Chemical
Industries, Tokyo, Japan) and the mobile phase consisted of n-
hexane : isopropanol (87.5 : 12.5, v/v) at a flow rate of 1.0 mL
min1.15 The two peaks corresponding to ()-(S)-NTD and
(+)-(R)-NTD were collected at the end of the column, the solvent
was evaporated and the residues were analyzed under the
conditions established in the present paper and the elution order
established.
The elution order for the NMD enantiomers was based on the
work described by Barbato et al.14 These authors employed a
Chiral AGP 100  4.0 mm id, 5 mm particle size (Chromtech,
H€agersten, Sweden) using a mobile phase which consisted of
isopropanol: 0.01 mol L1 phosphate-buffered saline pH 7.0
(10 : 90, v/v) and flow rate of 0.9 mL min1. In this condition the
two peaks corresponding to ()-(S)-NMD and (+)-(R)-NMD
were collected separately at the end of the column, the solvent
was evaporated and the residues were analyzed under the
conditions established in the present paper and the elution order
established.
Fig. 1 Chemical structure of nitrendipine (NTD); nimodipine (MND)
and nisoldipine (NSD) (* denotes the chiral center).
2954 | Anal. Methods, 2012, 4, 2953–2961 This journal is ª The Royal Society of Chemistry 2012
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For NSD, the elution order was based on the work described
by Marques et al.16 These authors employed a Chiralcel OD-H
column 250  4.6 mm id, 5 mm particle size (Diacel Chemical
Industries, California, USA) using hexane : ethanol (97.5 : 2.5, v/
v) to resolve the NSD enantiomers. Under these conditions the
separated enantiomers, (+)-(S)-NSD and ()-(R)-NSD, were
collected at the end of the column, the solvent was evaporated
and the residues were analyzed by CE under the conditions
established in the present paper.
Validation studies
Calibration curves were prepared by analyzing 25 mL working
solutions at different concentrations of each enantiomer of NTD
(2.5, 5.0, 10.0, 20.0, 40.0, 50.0 and 100.0 mg mL1), NMD (1.0,
2.5, 5.0, 20.0, 50.0, 60.0 and 100.0 mg mL1) and NSD (50.0,
100.0, 200.0, 300.0, 400.0, 500.0 and 600.0 mg mL1). Plots of
concentrations versus peak area were constructed and then sub-
jected to regression analysis by the least-squares method to
calculate the linear equation and correlation coefficient (r).
The LOQ values were taken from the calibration line. The
LOQ for each drug was considered the lowest value of the curve,
provided it has adequate precision and accuracy.
The precision and accuracy of the method were evaluated by
within-day and between-day assays. To assess within-day preci-
sion and accuracy, triplicate analysis of samples at three
concentration levels of NTD (10.0, 50.0 and 100.0 mg mL1),
NMD (5.0, 20.0 and 50.0 mg mL1) and NSD (100, 400 and 600
mg mL1) were performed. For between-day assays, triplicate
samples of each concentration were analyzed for three consecu-
tive days. Precision was expressed as relative standard deviation
(RSD %) and accuracy as relative error (RE %).
Forced degradation studies
Forced degradation studies were performed on the bulk drug to
provide an indication of the stability-indicating property and
specificity of the proposed method to separate API enantiomers
from their degradation products. Intentional degradation was
carried out in stress conditions of light (visible and ultra-violet
(UV)), pH and temperature.
Temperature. For NTD, a 50 mL working solution of NTD
(100 mg mL1) was transferred to glass tubes and the solvent was
evaporated under an air flow at room temperature. The residues
of NTD were supplemented with 2 mL sodium phosphate buffer
0.1 mol L1, pH 10.0 and the tubes were incubated at different
temperatures (20, 4 and 37 C). Aliquots (100 mL) of these
spiked samples (n ¼ 3) were analyzed at 0, 24, 48 and 72 hours
after incubation. The concentration of these samples was deter-
mined using a calibration curve.
Due to solubility problems, the thermal stability studies of
NMD and NSD were carried out in methanol. For this, a 25 mL
working solution of NMD (100 mg mL1) was transferred to ten
glass tubes. These tubes were incubated at 37 C for different
times: 0, 1, 2 and 9 days. After each period of incubation, two
tubes were removed, the solvent evaporated under a flow of
compressed air, and the residues were dissolved in 50 mL mobile
phase and analyzed. Considering the long period of time of the
experiments, the tubes were monitored daily and, when neces-
sary, methanol was added to prevent the complete evaporation of
the solvent, thereby preventing adsorption of NMD in the glass
extraction tube. For the temperatures of20 C and 4 C, a 2 mL
working solution (100 mg mL1) was transferred to glass tubes
and incubated at the two different temperatures. After exposing
the samples for 0, 1, 2 and 9 days, aliquots of 25 mL, in triplicate,
were removed. The solvent was evaporated under a flow of
compressed air and the residues were dissolved in a 50 mL mobile
phase and analyzed. The concentration of these samples was
determined using a calibration curve.
For NSD, a 25 mL working solution (500 mg mL1) was
transferred to glass tubes and 500 mL of methanol was added and
the tubes were incubated at 4 C and 37 C. After each incuba-
tion time (0, 24, 48 and 72 hours), three tubes were removed, the
solvent was evaporated under a flow of compressed air and the
residues were dissolved in 250 mL BGE and analyzed. In this case,
the tubes were also monitored daily and, when necessary, more
methanol was added to prevent the complete evaporation of the
solvent. The concentration of these samples was determined
using a calibration curve.
UV and visible light. For this study, a 25 mL standard solution
of NTD (20 mg mL1), NMD (20 mg mL1) and NSD (500 mg
mL1) in methanol was exposed to UV (254 nm) or visible light
for several periods of time (energy source at 10 cm from the
sample). To prevent the sample tube from drying due to evapo-
ration of the solvent (caused by heat from the UV light), 500 mL
of methanol was added to each tube when necessary. All analyses
were performed in triplicate (n ¼ 3).
The stability of the NTD enantiomers under UV (254 nm) light
was evaluated after 0, 1, 2, 3 and 4 hours and in visible light after
0, 1, 2, 3 and 4 days. After exposure to light, the solvent was
evaporated under compressed air at room temperature. The
residues were dissolved in 100 mL of the mobile phase and 20 mL
were injected into the HPLC equipment in the conditions
previously established.
For NMD, the study was performed at time intervals of 0, 1, 2,
3 and 4 hours and 0, 2, 3, 4 and 5 days for UV (254 nm) and
visible light, respectively. After exposure to light the solvent was
evaporated and the residues were dissolved in 100 mL of the
mobile phase and 20 mL was injected into the HPLC equipment
under the conditions previously established.
For NSD, this study was performed only under UV light
(254 nm). The tubes were removed at time intervals of 0, 10, 20
and 40 minutes. After exposing the samples to the action of UV
light, the solvent was evaporated under a flow of compressed air
and the residues were dissolved in 250 mL of BGE and analyzed.
To determine the concentration of the drugs, calibration
curves of the racemic mixture were prepared and analyzed for the
NTD, NMD and NSD enantiomers.
pH. For the stability study of NTD at different pH values, a
0.1 mol L1 sodium phosphate buffer was used and the pH was
adjusted to 4.0, 7.0 and 10.0 with a NaOH solution. For this
study a 50 mL standard solution of NTD (100 mg mL1) was
dried and dissolved by adding 2 mL of 0.1 mol L1 sodium
phosphate buffer solution. The solutions were then stored at 4 C
and aliquots of these spiked sample solutions (n ¼ 3) were
This journal is ª The Royal Society of Chemistry 2012 Anal. Methods, 2012, 4, 2953–2961 | 2955
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withdrawn and analyzed after 0, 3, 24, 48 and 72 hours of
incubation. For the stability study of NMD (100 mg mL1) the
experimental procedure was identical to that of NTD.
For NSD, this study was performed in two pH values only, 4.0
and 9.0; a sodium acetate buffer and sodium phosphate buffer
were used respectively. In this case a 250 mL standard solution of
NSD (1000 mg mL1) in methanol was mixed with 250 mL of
buffer solution (sodium acetate buffer pH 4.0 or sodium phos-
phate buffer pH 9.0). Aliquots (25 mL) of spiked sample solutions
(n ¼ 3) were withdrawn and 225 mL of buffer were added. The
samples were analyzed at 0, 24, 48 and 72 hours after incubation.
The concentration of these spiked samples was determined
using a calibration curve for each analyte.
Statistical analysis
All values were expressed as mean S.E.M. Differences between
incubation times were compared by one-way ANOVA and
Dunnet’s Test was used for comparison with the control time
(a ¼ 0.05).
Results and discussion
Method development
Nitrendipine and nimodipine. The optimization of analyses
conditions of NTD and NMD were based on the method
described by Barbato et al.14 Some modifications were preformed
to improve the resolution of enantiomers. Several mobile phases
consisting of different proportions of buffer and organic solvent
were tested (Table 1). In addition, the ionic strength using
sodium chloride was also tested: the same conditions above were
analyzed using 0.016, 0.026 or 0.066 mol L1 NaCl. The organic
and aqueous phase proportions were adjusted to obtain a simple
NTD and NMD assay method with a reproducible and rapid run
time.
The best analytical conditions for NTD were the mobile phase
n 8 (Table 1) with ionic strength (NaCl) 0.026 mol L1 at a flow
rate of 0.65 mLmin1; and for NMDwere the mobile phase no. 4
(Table 1) with ionic strength (NaCl) 0.066 mol L1 at a flow rate
of 0.65 mL min1.
Fig. 2 shows the typical chromatograms of separation of NTD
(Fig. 2A) and NMD (Fig. 2B) enantiomers.
Nisoldipine. The optimization of analysis conditions of NSD
was based on the CE method described by Van Eeckhaut et al.17
These authors used 60 mmol L1 boric acid, pH 5.5 with meth-
anol 15% (v/v) as BGE, and carboxymethyl-b-cyclodextrin (CM-
b-CD) as chiral selector. But with these conditions it was not
possible to detect the drug before 60 minutes had elapsed. For
this reason some modifications were preformed to achieve the
resolution of enantiomers, such as boric acid substitution by
sodium borate buffer solution as BGE.
So, the selected electrophoretic conditions were: 50 mmol L1
sodium borate buffer, pH 9.0, 15%methanol, 5 mmol L1 CM-b-
CD, voltage at 20 kV, temperature at 20 C, hydrodynamic
injection (10 seconds at 40 mbar) and detection at 227 nm.
Fig. 2C shows the electropherogram corresponding to a sepa-
ration of NSD enantiomers.
Elution order
To establish the elution order, the pure stereoisomers (obtained
by semi-preparative analysis under the conditions presented in
the present paper) were analyzed using the techniques of high
performance liquid chromatography and capillary electropho-
resis. The retention and migration times of the stereoisomers
from both studies were then compared and the elution order was
established as follows: the first enantiomer was ()-(S)-NTD
followed by (+)-(R)-NTD; in the case of NMD the first was
()-(S)-NMD followed by (+)-(R)-NMD and for NSD the first
Table 1 Mobile phases used on optimization of analyses conditions of
NTD and NMD
Mobile
Phase (n)
Sodium
phosphate
buffer 4 mM (%) Solvents (%)
pH 7.0 pH 7.1 2-Propanol Acetonitrile Methanol
1 87 — 13 — —
2 86 — 12 2 —
3 86 — 12 — 2
4 — 87 13 — —
5 — 86 12 2 —
6 — 86 12 — 2
7 — 85 7 — 8
8 85 — 7 — 8
Fig. 2 Typical chromatogram showing the resolution of NTD (A) and
NMD (B) enantiomers, and typical electropherogram showing the reso-
lution of NSD enantiomers (C). For analysis conditions see the text.
2956 | Anal. Methods, 2012, 4, 2953–2961 This journal is ª The Royal Society of Chemistry 2012
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enantiomer was ()-(R)-NSD followed by (+)-(S)-NSD, as
shown in Fig. 2.
Method validations
The chromatograms and the electropherogram appearing in
Fig. 2 indicate no interference. The calibration curve was
prepared by plotting the peak area of analytes against drug
concentration. Peak area and concentration were subjected to
least-squares linear regression analysis to calculate the calibra-
tion equation and correlation coefficient (r). The linear equa-
tions, correlation coefficient and RSD (%) are shown in Table 2.
All r values were $ 0.99, showing excellent linearity, and the
points in residual plots are randomly dispersed around the
horizontal axis showing that the linear regression model is
appropriate for the data.
For the purpose of calculating the LOQ the lowest concen-
tration on the analytical curve linearity was considered. The
values for the LOQ are also shown in Table 2.
The precision and accuracy of the methods were evaluated by
calculating RSD (%) and RE (%), respectively, for three deter-
minations of analytes at three different concentrations over the
course of three days under the same experimental conditions.
Table 3 shows within-day (n ¼ 3, three replicates for each
concentration) and between-day (n ¼ 3, on three different days)
assays. These results confirm the precision and accuracy of the
method within the desired range.
Forced degradation studies
Investigations on drug-stability are gaining great pharmaceutical
relevance because they are important factors to determine both
efficiency and toxicity, since changes in the structure induce
changes in the drug’s pharmacological properties with a lack of
therapeutic effect. For this reason the stability of the compounds
of interest was tested under different conditions.
Temperature.Marciniec and Ogrodowczyk18 studied the effect
of temperature and moisture on the stability of seven 1,4-dihy-
dropyridine derivatives and they showed there was degradation
of all dihydropyridines at high temperatures of 70, 80 and 90 C
and 76% humidity. Therefore it is necessary to obtain results at
different temperatures which might be encountered in storage
and use.
Table 2 Linearity, limits of detection and quantification of the methods
Parameters Nitrendipine Nimodipine Nisoldipine
Linear equationa ()-(S) y ¼ 354.98x – 73.316 ()-(S) y ¼ 10 918x – 50.745 ()-(R) y ¼ 0.0897x – 1.7201
(+)-(R) y ¼ 326.52x – 214.05 (+)-(R) y ¼ 19 991x – 7171.1 (+)-(S) y ¼ 0.0805x – 0.5267
Correlation coefficient (r) ()-(S) 0.9992 ()-(S) 0.9985 ()-(R) 0.9989
(+)-(R) 0.9997 (+)-(R) 0.9983 (+)-(S) 0.9984
Range (mg mL1) ()-(S) 2.0–120 ()-(S) 1.0–100 ()-(R) 100–600
(+)-(R) 2.0–120 (+)-(R) 1.0–100 (+)-(S) 100–600
LOQ (mg mL1) ()-(S) 2.0 ()-(S) 1.0 ()-(R) 100
(+)-(R) 2.0 (+)-(R) 1.0 (+)-(S) 100
a Calibration curves were analyzed in triplicate (n ¼ 3) for each concentration: y ¼ Ax + B; where y is the peak area of analyte, A is the slope, B is the
intercept, and x is the concentration of the measured solution in mg mL1.
Table 3 Precision and accuracy of the methods for the determination of NTD, NMD and NSD enantiomers
Drug
Nominal concentration
(mg mL1)
Within-day (n ¼ 3)a Between-day (n ¼ 3)b
Obtained (mg mL1) RE (%)c RSD (%)d Obtained (mg mL1) RE (%)c RSD (%)d
()-(S)-NTD 10 9.75 2.55 5.62 9.83 1.73 5.00
50 50.26 0.52 6.55 50.24 0.49 4.25
100 102.44 2.44 2.97 100.89 0.89 2.89
(+)-(R)-NTD 10 10.08 2.82 3.25 10.03 0.28 2.80
50 51.53 3.05 6.7 51.01 2.01 4.91
100 100.14 0.14 6.44 99.55 0.45 4.98
()-(S)-NMD 5 4.60 8.10 4.24 4.87 2.70 5.76
20 19.74 1.31 3.84 21.33 6.94 9.53
50 46.33 7.30 1.84 46.35 7.30 6.13
(+)-(R)-NMD 5 4.85 2.93 5.04 4.67 6.60 5.92
20 21.37 6.85 3.27 20.70 3.51 8.76
50 46.69 6.62 1.70 51.11 2.22 7.72
()-(R)-NSD 100 98.88 1.12 0.72 94.98 5.02 4.64
400 381.70 4.57 4.61 390.13 2.46 3.85
600 600.75 0.12 3.10 602.15 0.36 2.85
(+)-(S)-NSD 100 103.16 3.16 2.49 97.12 2.88 6.92
400 382.98 4.25 1.65 319.95 2.01 3.29
600 641.12 6.85 2.55 606.24 1.04 2.39
a n ¼ Number of determinations. b n ¼ Number of days. c RE, expressed as relative error in percentage (%). d RSD, expressed as relative standard
deviation in percentage (%).
This journal is ª The Royal Society of Chemistry 2012 Anal. Methods, 2012, 4, 2953–2961 | 2957
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Both enantiomers, ()-(S)-NTD and (+)-(R)-NTD, were
found not to decompose at 20 C during thermodegradation
studies. However ()-(S)-NTD showed a small degradation
which proved to be statistically significant (P < 0.05), after 72
hours at both 4 and 37 C (Fig. 3A).
In the case of NMD (Fig. 3B), under the same conditions but
for a longer time, it was observed that at 37 C, both enantiomers
()-(S)-NMD and (+)-(R)-NMD were degraded after nine days
of study (P < 0.001), while at 20 C and 4 C, no statistically
significant degradation was observed for both enantiomers.
For NSD, no degradation during the test was observed for
both enantiomers (Fig. 3C).
UV and visible light. Many articles show that the dihy-
dropyridines when exposed to light lead to decomposition.19–22
The chemical changes in irradiated molecules include the
oxidation of the dihydropyridine ring of pyridine and the
reduction of the aromatic nitro group to the nitroso group.
Depending on the source of irradiation, two different products
can be obtained: nitrophenylpyridine and nitrosophenylpyridine,
resulting from exposure to UV and visible light respectively.16
These pyridine analogues may not have a therapeutic effect.21
NTD was found to be photosensitive for both enantiomers
(Fig. 4A). Exposure to UV light caused 51.64% of ()-(S)-NTD
and 54.82% of (+)-(R)-NTD degradation of the sample within
one hour and 82.52% of ()-(S)-NTD and 85.83% of (+)-(R)-
NTD within four hours (P < 0.05). In the present study it was
observed that the degradation product was already present in the
standard powder, but in a small amount. This fact was confirmed
by the increase of peak of the degradation product after exposure
to UV light (Fig. 5A). On the other hand, there was no statisti-
cally significant difference in up to three days of study (P > 0.05),
in visible light. This behavior can be explained by the lower
intensity of energy supplied by visible light.
In the case of NMD under UV light conditions, its enantio-
mers were found to be more stable than NTD enantiomers.
Exposure to UV light caused a degradation of NMD enantio-
mers of 40.57% for ()-(S)-NMD and 38.66% for (+)-(R)-NMD
after one hour while the exposure to UV light for four hours
caused 63.13% of ()-(S)-NMD and 60.10% of (+)-(R)-NMD
Fig. 3 Influence of temperature on the stability of the drugs NTD (A); NMD (B) and NSD (C). Each bar represents the mean  S.E.M. The symbols
adjacent to the bars represent the P value, with a level of significance of 95% (one-way ANOVA followed by Dunnet’s post-test), when compared with
the fresh sample. *P < 0.05; **P < 0.01; ***P < 0.001.
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degradation (P < 0.05) (Fig. 4B). In the same way as shown for
NTD, the formation of a degradation product was also observed
for NMD (Fig. 5B). Both enantiomers, ()-(S)-NMD and
(+)-(R)-NMD, when exposed to visible light were degraded after
two days of exposure (P < 0.05), but the formation of any
degradation product was not observed, such as when the enan-
tiomers were exposed to UV light.
For NSD, shorter analysis times were required due to its high
sensitivity to UV light. The percent of decomposition for NSD
enantiomers was 37.21% for ()-(R)-NSD and 37.11% for
(+)-(S)-NMD after 10 minutes and 59.99% for ()-(R)-NSD and
60.72% for (+)-(S)-NMD after 40 minutes of UV light exposure
(Fig. 4C). These results are corroborated by Baranda et al.,13 in
which the authors did not find any detectable compound after 2 h
of light exposure. In this case a chiral degradation product is
observed at a retention time of 12.5 minutes (Fig. 5C).
As explained above, special precautions against light exposure
must be taken when working with dihydropyridines; this is due to
the fact that dihydropyridines are easily photodegraded when
exposed to light.
pH. Among the factors that can alter the solubility and
stability of drugs, we can cite pH. pH has great importance in the
drug effect, since most drugs are weak acids or bases, and pH is
still closely related to the absorption and stability of the drugs.23
For this reason the stability study of drugs in different pH values
is essential.
For ionizable drugs, such as NTD, which present a weakly
basic character, the fraction of a drug present in any particular
form will depend on the pH solution. So, changes in the pH of the
medium altered the solubility of NTD enantiomers (data not
shown). For this reason, if the reactivity of the NTD enantiomers
depends on their form (ionized), in a high pH value, lower
degradation will be observed, as shown in Fig. 6A. The effect of
pH on the degradation rate of NTD enantiomers can be
explained by the catalytic effects that hydronium or hydroxide
Fig. 4 Influence of UV and visible light on the stability of the drugs NTD (A); NMD (B) and NSD (C). Each bar represents the mean  S.E.M. The
symbols adjacent to the bars represent the P value, with a level of significance of 95% (one-way ANOVA followed by Dunnet’s post-test), when
compared with the fresh sample. *P < 0.05; **P < 0.01; ***P < 0.001.
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ions may have on the chemical reactions. Degradation rates of
drug substances are generally affected by pH because most
degradation pathways are catalyzed by hydronium and/or
hydroxide ions.24
For NMD some difficulties in solubilization during the
stability study at different pH values were found. Here, some
modifications to the solution were made such as: changes in the
volume of resuspension buffer, addition of surfactants, and
addition of standard solution without drying the solvent. After
these modifications the same improvements in solubility were
achieved. On the other hand, the worst resolution was achieved
between NMD enantiomers. Thus, due to the difficulty found in
the solubilization of the drug in aqueous medium, the stability
study in this condition cannot be undertaken.
In the case of NSD, a neutral drug, no degradation during the
stability study was observed for both enantiomers at both pH
values (Fig. 6B). This fact can be explained by low and/or no
ionization of the drug, which reduces the reactivity of the groups
to acid or basic hydrolysis.
Conclusion
Efficient stereoselective methods were developed and validated.
The proposed methods have the ability to separate these drugs
from their degradation products and can be applied to the
analysis of samples obtained during accelerated stability experi-
ments. From the stability tests it can be concluded that temper-
ature and pH had little influence on the stability of drugs during
the studies, but precautions against light exposure must be taken
when working with dihydropyridines, since this class of drugs has
a high rate of degradation under light.
Fig. 6 Influence of pH on the stability of the drugs. Each bar represents the mean S.E.M. The symbols adjacent to the bars represent the P value, with
a level of significance of 95% (one-way ANOVA followed by Dunnet’s post-test), when compared with the fresh sample. *P < 0.05; **P < 0.01; ***P <
0.001.
Fig. 5 Typical chromatograms of NTD (A) and NMD (B), and a typical
electropherogram of NSD (C) after exposure to UV light. *PDP –
principal degradation product. For analysis conditions see the text.
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